Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$588M |
| 2 |
UnitedHealth
UNH
|
+$429M |
| 3 |
Johnson & Johnson
JNJ
|
+$333M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$322M |
| 2 |
JPMorgan Chase
JPM
|
+$304M |
| 3 |
K
Kellanova
K
|
+$164M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Financials | 18.7% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 10.44% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Caribou Biosciences
CRBU
$145M
| $1.26M | ﹤0.01% |
1,384,669
-347,709
| -20% | -$452K |
|
|
ADVM
2827
DELISTED
Adverum Biotechnologies
ADVM
| $1.26M | ﹤0.01% |
287,794
-23,211
| -7% | -$105K |
|
2828
Richmond Mutual Bancorp
RMBI
$251M
| $1.25M | ﹤0.01% |
97,900
+4,692
| +5% | +$61.7K |
|
2829
GrowGeneration
GRWG
$86.5M
| $1.25M | ﹤0.01% |
1,158,191
-222,950
| -16% | -$299K |
|
2830
CleanSpark
CLSK
$3.53B
| $1.25M | ﹤0.01% |
186,035
-3,606,679
| -95% | -$34.2M |
|
|
NAGE
2831
Niagen Bioscience
NAGE
$271M
| $1.25M | ﹤0.01% |
181,099
+58,177
| +47% | +$366K |
|
2832
Cytokinetics
CYTK
$10.5B
| $1.25M | ﹤0.01% |
31,034
-63,090
| -67% | -$2.9M |
|
2833
Wolfspeed
WOLF
$1.23B
| $1.24M | ﹤0.01% |
406,861
-146,092
| -26% | -$854K |
|
2834
Citizens
CIA
$239M
| $1.24M | ﹤0.01% |
271,971
+2,390
| +0.9% | +$11.5K |
|
2835
Golar LNG
GLNG
$5B
| $1.24M | ﹤0.01% |
32,541
+15
| +0% | +$588 |
|
2836
Codexis
CDXS
$151M
| $1.23M | ﹤0.01% |
458,616
+52,641
| +13% | +$204K |
|
2837
Rubrik
RBRK
$14.9B
| $1.23M | ﹤0.01% |
20,199
-16,542
| -45% | -$1.13M |
|
2838
Grab
GRAB
$14.3B
| $1.23M | ﹤0.01% |
271,745
+50,097
| +23% | +$234K |
|
2839
Loar Holdings
LOAR
$6.41B
| $1.23M | ﹤0.01% |
17,406
+12,195
| +234% | +$880K |
|
|
GRAL
2840
GRAIL Inc
GRAL
$2.94B
| $1.22M | ﹤0.01% |
47,911
-241
| -0.5% | -$7.45K |
|
2841
Monte Rosa Therapeutics
GLUE
$1.4B
| $1.22M | ﹤0.01% |
262,990
+118,179
| +82% | +$725K |
|
2842
Crexendo
CXDO
$223M
| $1.21M | ﹤0.01% |
247,506
+29,858
| +14% | +$175K |
|
2843
Alto Ingredients
ALTO
$369M
| $1.19M | ﹤0.01% |
1,046,231
-221,564
| -17% | -$343K |
|
2844
Chegg
CHGG
$110M
| $1.19M | ﹤0.01% |
1,865,988
-272,536
| -13% | -$338K |
|
2845
Symbotic
SYM
$5.48B
| $1.19M | ﹤0.01% |
58,905
+9,124
| +18% | +$233K |
|
2846
Union Bankshares
UNB
$106M
| $1.18M | ﹤0.01% |
37,486
+2,210
| +6% | +$67.4K |
|
2847
Full House Resorts
FLL
$80.1M
| $1.18M | ﹤0.01% |
282,168
-4,152
| -1% | -$19.6K |
|
2848
IonQ
IONQ
$13.6B
| $1.17M | ﹤0.01% |
53,238
+4,218
| +9% | +$137K |
|
2849
Rigel Pharmaceuticals
RIGL
$681M
| $1.17M | ﹤0.01% |
65,300
+48,177
| +281% | +$977K |
|
|
YSG
2850
Yatsen Holding
YSG
$322M
| $1.17M | ﹤0.01% |
242,082
+28,252
| +13% | +$110K |
|
Similar funds
Dimensional Fund Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Dimensional Fund Advisors held 3,398 positions worth $402B, down 3.4% from $416B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4%. Dimensional Fund Advisors opened 59 new positions and exited 78, leaving the 3,398-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2025 buy was Sandisk: 849,963 shares worth $40.5M.
- Dimensional Fund Advisors added most to Apple in Q1 2025, an estimated $588M increase.
- Dimensional Fund Advisors's biggest Q1 2025 reduction was Expand Energy Corp, cutting an estimated $322M.
- Dimensional Fund Advisors fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $159M.
- Dimensional Fund Advisors's ten largest holdings make up 15% of its $402B portfolio in Q1 2025.
- Dimensional Fund Advisors opened 59 new positions and closed 78 in Q1 2025.
- Dimensional Fund Advisors's portfolio value fell 3.4% quarter-over-quarter to $402B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.